Cognex Corp. 10-Q Summary: Period Ended July 2, 1995
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended July 2, 1995, and the six-month period ended July 2, 1995. Cognex Corporation is a developer of machine vision systems. As of July 30, 1995, there were 19,209,169 shares of Common Stock outstanding.
Key Financial Metrics
| Metric | 3 Months Ended July 2, 1995 | 6 Months Ended July 2, 1995 |
|---|---|---|
| Revenue | $23.72 million | $43.16 million |
| Gross Margin | $18.49 million (78%) | $33.97 million (79%) |
| Net Income | $7.24 million | $13.11 million |
| Diluted EPS | $0.35 | $0.64 |
| Operating Cash Flow | N/A | $6.48 million |
| Cash & Investments | $82.89 million (Total) | $82.89 million (Total) |
| Debt | $0 | $0 |
| Working Capital | $100.57 million | $100.57 million |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 59% for the quarter and 55% for the six-month period compared to 1994. International revenue grew 56% in both periods.
- Profitability: Net income more than doubled, rising from $3.68 million to $7.24 million for the quarter and from $6.88 million to $13.11 million for the six-month period.
- Product Mix: Sales of the newer Cognex 5000 Series grew to 29% of revenue for the quarter (up from 24% in 1994), while the share of older 2000/3000 and 4000 Series products declined.
- Expense Management: R&D and SG&A expenses increased in absolute dollars but decreased as a percentage of revenue due to revenue growth outpacing cost increases.
- Liquidity: Cash and cash equivalents decreased from $56.33 million to $23.32 million, while investments increased from $25.17 million to $59.57 million. The net decrease in cash was driven by investing activities, including the purchase of an office building and investments.
Outlook, Risks, and Unusual Items
- Acquisition: On July 21, 1995, Cognex acquired Acumen, Inc. for approximately $14 million ($8.5 million cash, stock, and options). A significant portion of the purchase price is expected to be charged to third-quarter earnings for in-process technology.
- Capital Expenditures: The company purchased an 83,000 sq. ft. office building for $5.3 million in June 1995. A planned 50,000 sq. ft. addition to headquarters is expected to cost between $5 million and $6 million, payable through Q1 1997.
- Liquidity Position: The company has no outstanding debt and a $1 million unsecured line of credit. Management believes existing cash and operating cash flow are sufficient to meet requirements through 1995.
- Stock Authorization: Shareholders approved an increase in authorized common stock from 25 million to 60 million shares.
Investor Verification Checklist
- Verify the impact of the Acumen, Inc. acquisition on Q3 1995 earnings, specifically the charge for in-process technology.
- Confirm the timeline and final cost of the headquarters expansion project ($5M-$6M).
- Monitor the sustainability of the 78-79% gross margin as the product mix shifts toward newer series.
- Review the utilization of the $1 million line of credit and the status of its extension beyond August 1995.
- Assess the integration of Acumen's semiconductor wafer identification technology into Cognex's existing portfolio.